Source comparison
Peptide Comparison — Mechanisms, Dosing, and Research Applications
CJC-1295 (with DAC) GHRH receptor 6–8 days 30–60 mcg/kg weekly 2–6 hours Minimal Sustained GH elevation, anti-aging models Ipamorelin GHS-R1a (ghrelin) 2 hours 200–300 mcg 2–3×/day 30–60 minutes None (highly selective) Isolated GH modulation, metabolic studies
This comparison does not assign a generated winner or score.
- CJC-1295 (with DAC)
- GHRH receptor
- 6–8 days
- 30–60 mcg/kg weekly
- 2–6 hours
- Minimal
- Sustained GH elevation, anti-aging models
- Ipamorelin
- GHS-R1a (ghrelin)
- 2 hours
- 200–300 mcg 2–3×/day
- 30–60 minutes
- None (highly selective)
- Isolated GH modulation, metabolic studies
- GHRP-2
- 20–30 minutes
- 100–200 mcg 2–3×/day
- 15–30 minutes
- Cortisol ↑, Prolactin ↑
- Acute GH pulse research
- Hexarelin
- GHS-R1a + CD36
- 60 minutes
- 2 mcg/kg IV
- Cortisol ↑, cardiac receptor binding
- Short-term high-amplitude GH studies
- Sermorelin
- 8–12 minutes
- 100–200 mcg 2×/day
- 30–90 minutes
- Circadian GH pulse research
- MK-677
- GHS-R1a (oral)
- 4–6 hours
- 10–25 mg daily
- 90–120 minutes
- Cortisol ↑ (dose-dependent)
- Oral GH secretagogue models, appetite studies